General
| Peptide: | RIJK3 |
| Microorganism: | Klebsiella pneumoniae LM21 |
| Administration: | |
| Stage: | Formation (3-24h) |
| Notes: | In a BioFlux Microfluidics System |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Confocal microscopy-fluorescence | > 90% | 6.766 uM |
Reference
- César de la Fuente-Núñez, Fany Reffuveille, Sarah C. Mansour, Shauna L. Reckseidler-Zenteno, Diego Hernández, Gilles Brackman, Tom Coenye, Robert E.W. Hancock D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com